100 VANGUARD BOULEVARD,
MALVERN , PA, 19355
MALVERN , PA, 19355
Summary
Link
Directors
Nov 14, 2023- Tara Bunch
- Grant Reid
- F. Joseph Loughrey
- Mortimer J. Buckley
- Scott C. Malpass
- Andre F. Perold
- Sarah Bloom Raskin
- Deanna Mulligan
- Mark Loughridge
- David Thomas
- Peter F. Volanakis
- Emerson U. Fullwood
Chief Compliance Officer
- Jacqueline Angell
Fund Manager(s)
- Walter Nejman
- Nick Birkett
Price
- 52-Week High/Low
- $342.33 - $283.65
- Turnover
- 19.4%
- Expense Ratio
- 0.07%
Company Name |
Holding |
Procter & Gamble Co/The | 1.46 % |
AT&T Inc | 0.61 % |
S&P Global Inc | 0.58 % |
Analog Devices Inc | 0.54 % |
Medtronic PLC | 0.5 % |
Thermo Fisher Scientific Inc | 0.39 % |
Duke Energy Corp | 0.37 % |
Phillips 66 | 0.29 % |
CSX Corp | 0.27 % |
Aon PLC | 0.26 % |
More | 0.26 % |
Documents
Performance
YTD
-
3 Year
17.06%
5 Year
41%
Best
32.39%
2013
Worst
-9.69%
2022
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|---|
Q1 | - | 8.5% | 0.5% | -1.2% | 9.7% | -27.4% | 11.3% | -2.9% | 3.2% | 1.6% |
Q2 | - | -0.9% | 3.5% | -12.7% | 6.7% | 13.5% | 2% | 3.4% | 1.3% | 4.5% |
Q3 | - | - | -3.7% | -6.2% | -2.8% | 3.5% | 0.1% | 5.7% | 3.1% | 3.5% |
Q4 | - | - | 10% | 11.7% | 7.8% | 16.2% | 6.7% | -12% | 4.7% | 6.7% |
J | F | M | A | M | J | J | A | S | O | N | D | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | - | - | - | - | - | - | - | - | - | - | - | - |
2024 | 0.1% | 3.7% | 4.5% | -4.1% | - | - | - | - | - | - | - | - |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
0% | 4% | 9% | -10% | 23% | 0% | 23% | -8% | 14% | 17% |
Alpha
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|---|
VRVIX | - | 4% | 9% | -10% | 23% | - | 23% | -8% | 14% | 17% |
Russell 1000 | - | - | - | -14% | 23% | 0% | 23% | -11% | 11% | 14% |
Alpha | - | 4% | 9% | 4% | 0% | - | 0% | 2% | 3% | 3% |